Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
758 A phase 1 dose escalation and expansion study of the anti-CD200R1 antibody 23ME-00610 in patients with advanced solid malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.